Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-05

AUTHORS

Shaheeda Ahmed, C. Michael Gibson, Christopher P. Cannon, Sabina A. Murphy, Marc S. Sabatine

ABSTRACT

Reduced glomerular filtration rate (GFR) is associated with adverse outcomes in patients with cardiovascular disease. We explored the relationship between GFR and angiographic and clinical outcomes in ST-segment elevation myocardial infarction (STEMI) patients receiving pharamacologic reperfusion, with or without clopidogrel. Data were available to estimate GFR in 3,252 STEMI patients undergoing fibrinolysis, randomized to clopidogrel versus placebo in the CLARITY-TIMI 28 trial. Patients with a creatinine > 2.5 mg/dl were excluded from the trial. We compared outcomes between patients with no, mild or moderate reductions in baseline estimated GFR (ml/min/1.73 m²) of ≥ 90, 60-89, and <60, respectively. Compared to patients with no (n = 841) or mildly reduced GFR (n = 1897), those with moderately reduced GFR (n = 514) were older, more often female, and were more likely to have diabetes and hypertension (P ≤ 0.001 for all). The risk of the primary endpoint (an occluded infarct-related artery on angiography or death/myocardial infarction by day 8), 30 day cardiovascular events (death, myocardial infarction, or urgent revascularization for recurrent ischemia) and 30 day Thrombolysis in Myocardial Infarction (TIMI) major or minor bleeding increased as GFR declined (P for trend 0.003, <0.0001, and 0.0008 respectively). The adjusted risk of 30 day ischemic complications remained higher in patients with moderately reduced versus normal GFR (OR 1.5, 95% CI 1.0-2.1, P = 0.04). Treatment with clopidogrel tended to yield greater benefit in patients with normal or mildly reduced GFR versus in patients with moderately reduced GFR. In conclusion, STEMI patients with reduced GFR treated with medical reperfusion, including dual antiplatelet therapy, have higher rates of adverse clinical outcome. Further research on optimal STEMI therapy in this high-risk group is warranted. More... »

PAGES

493-500

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-011-0566-9

DOI

http://dx.doi.org/10.1007/s11239-011-0566-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050694479

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21318582


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Angiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibrinolysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerular Filtration Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombolytic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ticlopidine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Thrombolysis in Myocardial Infarction Study Group", 
          "id": "https://www.grid.ac/institutes/grid.492942.0", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham Women\u2019s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahmed", 
        "givenName": "Shaheeda", 
        "id": "sg:person.01170266326.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170266326.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thrombolysis in Myocardial Infarction Study Group", 
          "id": "https://www.grid.ac/institutes/grid.492942.0", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham Women\u2019s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michael Gibson", 
        "givenName": "C.", 
        "id": "sg:person.0750215673.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750215673.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thrombolysis in Myocardial Infarction Study Group", 
          "id": "https://www.grid.ac/institutes/grid.492942.0", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham Women\u2019s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cannon", 
        "givenName": "Christopher P.", 
        "id": "sg:person.01172544713.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172544713.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thrombolysis in Myocardial Infarction Study Group", 
          "id": "https://www.grid.ac/institutes/grid.492942.0", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham Women\u2019s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murphy", 
        "givenName": "Sabina A.", 
        "id": "sg:person.0714034144.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714034144.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thrombolysis in Myocardial Infarction Study Group", 
          "id": "https://www.grid.ac/institutes/grid.492942.0", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham Women\u2019s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sabatine", 
        "givenName": "Marc S.", 
        "id": "sg:person.01367356600.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367356600.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.jacc.2007.05.049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000216862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000027560.41358.b3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002360004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2004.11.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002554441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000189522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008486067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2008.07.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009216476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2003.06.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015730556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa041365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017147712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehl149", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025653553"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa050522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028133368"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000095676.90936.80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038647312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehp492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039022027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehp492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039022027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(02)02956-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041326817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(02)02956-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041326817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.101.2.125", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043155754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2009.10.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046464720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-008-0197-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047716313", 
          "https://doi.org/10.1007/s11239-008-0197-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ehj.2004.08.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054732660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2004-835678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057439294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.hjr.0000220582.19516.a6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060330237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.hjr.0000220582.19516.a6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060330237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-139-2-200307150-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073706427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075017372", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082398326", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-05", 
    "datePublishedReg": "2011-05-01", 
    "description": "Reduced glomerular filtration rate (GFR) is associated with adverse outcomes in patients with cardiovascular disease. We explored the relationship between GFR and angiographic and clinical outcomes in ST-segment elevation myocardial infarction (STEMI) patients receiving pharamacologic reperfusion, with or without clopidogrel. Data were available to estimate GFR in 3,252 STEMI patients undergoing fibrinolysis, randomized to clopidogrel versus placebo in the CLARITY-TIMI 28 trial. Patients with a creatinine > 2.5 mg/dl were excluded from the trial. We compared outcomes between patients with no, mild or moderate reductions in baseline estimated GFR (ml/min/1.73 m\u00b2) of \u2265 90, 60-89, and <60, respectively. Compared to patients with no (n = 841) or mildly reduced GFR (n = 1897), those with moderately reduced GFR (n = 514) were older, more often female, and were more likely to have diabetes and hypertension (P \u2264 0.001 for all). The risk of the primary endpoint (an occluded infarct-related artery on angiography or death/myocardial infarction by day 8), 30 day cardiovascular events (death, myocardial infarction, or urgent revascularization for recurrent ischemia) and 30 day Thrombolysis in Myocardial Infarction (TIMI) major or minor bleeding increased as GFR declined (P for trend 0.003, <0.0001, and 0.0008 respectively). The adjusted risk of 30 day ischemic complications remained higher in patients with moderately reduced versus normal GFR (OR 1.5, 95% CI 1.0-2.1, P = 0.04). Treatment with clopidogrel tended to yield greater benefit in patients with normal or mildly reduced GFR versus in patients with moderately reduced GFR. In conclusion, STEMI patients with reduced GFR treated with medical reperfusion, including dual antiplatelet therapy, have higher rates of adverse clinical outcome. Further research on optimal STEMI therapy in this high-risk group is warranted.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-011-0566-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis", 
    "pagination": "493-500", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f17d7a6e86a0cb9f195b2e4717b8e064ebdbd8a3a9042a8df6bbdbdf1b253032"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21318582"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-011-0566-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050694479"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-011-0566-9", 
      "https://app.dimensions.ai/details/publication/pub.1050694479"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000524.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-011-0566-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-011-0566-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-011-0566-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-011-0566-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-011-0566-9'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      21 PREDICATES      65 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-011-0566-9 schema:about N1a0295dc044442e9847dae98c5f247e0
2 N22e82f8899df480ea8b86d517f0edf24
3 N432710cecdeb457bae7f9b97fc8c539b
4 N55f60403c0e74e5eb84fd9c17971bebc
5 N6c80602bcbf4452a9e84bb6bad013e96
6 N7203d322d5df4c53b6163096d2acaf08
7 N7f08721d8c8641dc95c8414e110dd06d
8 N8e4d235831554fa3b0fa66c849742c87
9 Na7bb53ed1b034ca799783a1e69d8ecb0
10 Na90b9e38dc3448228840ded60ac722ac
11 Nb85b676f3a2d45118e890c87c349b73f
12 Nbb5bc713db1a4a849e19fb8310e2e5de
13 Ncf47bc261f4d49d184e084e00c843acc
14 Ned4bbed6b3ed4dfe9dc191ea261a3cf1
15 Nee2b0ed244e64a22804875d73ce77aa7
16 anzsrc-for:11
17 anzsrc-for:1102
18 schema:author Nbc62b644141347a1975f0b23a24f2844
19 schema:citation sg:pub.10.1007/s11239-008-0197-y
20 https://app.dimensions.ai/details/publication/pub.1075017372
21 https://app.dimensions.ai/details/publication/pub.1082398326
22 https://doi.org/10.1016/j.ahj.2004.11.006
23 https://doi.org/10.1016/j.ahj.2008.07.029
24 https://doi.org/10.1016/j.ehj.2004.08.016
25 https://doi.org/10.1016/j.jacc.2003.06.001
26 https://doi.org/10.1016/j.jacc.2007.05.049
27 https://doi.org/10.1016/j.jacc.2009.10.043
28 https://doi.org/10.1016/s0735-1097(02)02956-x
29 https://doi.org/10.1055/s-2004-835678
30 https://doi.org/10.1056/nejmoa041365
31 https://doi.org/10.1056/nejmoa050522
32 https://doi.org/10.1093/eurheartj/ehl149
33 https://doi.org/10.1093/eurheartj/ehp492
34 https://doi.org/10.1097/01.hjr.0000220582.19516.a6
35 https://doi.org/10.1159/000189522
36 https://doi.org/10.1161/01.cir.0000027560.41358.b3
37 https://doi.org/10.1161/01.cir.0000095676.90936.80
38 https://doi.org/10.1161/01.cir.101.2.125
39 https://doi.org/10.7326/0003-4819-139-2-200307150-00013
40 schema:datePublished 2011-05
41 schema:datePublishedReg 2011-05-01
42 schema:description Reduced glomerular filtration rate (GFR) is associated with adverse outcomes in patients with cardiovascular disease. We explored the relationship between GFR and angiographic and clinical outcomes in ST-segment elevation myocardial infarction (STEMI) patients receiving pharamacologic reperfusion, with or without clopidogrel. Data were available to estimate GFR in 3,252 STEMI patients undergoing fibrinolysis, randomized to clopidogrel versus placebo in the CLARITY-TIMI 28 trial. Patients with a creatinine > 2.5 mg/dl were excluded from the trial. We compared outcomes between patients with no, mild or moderate reductions in baseline estimated GFR (ml/min/1.73 m²) of ≥ 90, 60-89, and <60, respectively. Compared to patients with no (n = 841) or mildly reduced GFR (n = 1897), those with moderately reduced GFR (n = 514) were older, more often female, and were more likely to have diabetes and hypertension (P ≤ 0.001 for all). The risk of the primary endpoint (an occluded infarct-related artery on angiography or death/myocardial infarction by day 8), 30 day cardiovascular events (death, myocardial infarction, or urgent revascularization for recurrent ischemia) and 30 day Thrombolysis in Myocardial Infarction (TIMI) major or minor bleeding increased as GFR declined (P for trend 0.003, <0.0001, and 0.0008 respectively). The adjusted risk of 30 day ischemic complications remained higher in patients with moderately reduced versus normal GFR (OR 1.5, 95% CI 1.0-2.1, P = 0.04). Treatment with clopidogrel tended to yield greater benefit in patients with normal or mildly reduced GFR versus in patients with moderately reduced GFR. In conclusion, STEMI patients with reduced GFR treated with medical reperfusion, including dual antiplatelet therapy, have higher rates of adverse clinical outcome. Further research on optimal STEMI therapy in this high-risk group is warranted.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf N4b6bfdb9d0ff49acace96ca650ca478b
47 Nb7393eb4a1754d568759cf8698813f05
48 sg:journal.1113719
49 schema:name Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis
50 schema:pagination 493-500
51 schema:productId N105e6dd8d0a645cbb57a3dc858b557a0
52 N3b64457570604f15af58fed3b4158ad5
53 N40ee40582f144879a29a5c66019f2e2f
54 Nd5476475b7bb4d3bb0bbee93e7ca43db
55 Nff5f80ec486c4e4092b8cfeac46093e0
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050694479
57 https://doi.org/10.1007/s11239-011-0566-9
58 schema:sdDatePublished 2019-04-11T02:11
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher N08c0071a551848888570e1eca02476c0
61 schema:url http://link.springer.com/10.1007%2Fs11239-011-0566-9
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N08c0071a551848888570e1eca02476c0 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N105e6dd8d0a645cbb57a3dc858b557a0 schema:name pubmed_id
68 schema:value 21318582
69 rdf:type schema:PropertyValue
70 N1a0295dc044442e9847dae98c5f247e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Glomerular Filtration Rate
72 rdf:type schema:DefinedTerm
73 N22e82f8899df480ea8b86d517f0edf24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Hemorrhage
75 rdf:type schema:DefinedTerm
76 N3b64457570604f15af58fed3b4158ad5 schema:name readcube_id
77 schema:value f17d7a6e86a0cb9f195b2e4717b8e064ebdbd8a3a9042a8df6bbdbdf1b253032
78 rdf:type schema:PropertyValue
79 N40ee40582f144879a29a5c66019f2e2f schema:name doi
80 schema:value 10.1007/s11239-011-0566-9
81 rdf:type schema:PropertyValue
82 N432710cecdeb457bae7f9b97fc8c539b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Middle Aged
84 rdf:type schema:DefinedTerm
85 N4b6bfdb9d0ff49acace96ca650ca478b schema:issueNumber 4
86 rdf:type schema:PublicationIssue
87 N55f60403c0e74e5eb84fd9c17971bebc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Female
89 rdf:type schema:DefinedTerm
90 N5ee822f26efc4408b1701e097afb5f8e rdf:first sg:person.01367356600.00
91 rdf:rest rdf:nil
92 N6c80602bcbf4452a9e84bb6bad013e96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Adolescent
94 rdf:type schema:DefinedTerm
95 N7203d322d5df4c53b6163096d2acaf08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Myocardial Infarction
97 rdf:type schema:DefinedTerm
98 N7f08721d8c8641dc95c8414e110dd06d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Coronary Angiography
100 rdf:type schema:DefinedTerm
101 N8e4d235831554fa3b0fa66c849742c87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Male
103 rdf:type schema:DefinedTerm
104 Na125bffad4234c5ebc0cb37375e3637a rdf:first sg:person.0750215673.07
105 rdf:rest Necaaa571ef7e481793828ce6cd931dc6
106 Na7bb53ed1b034ca799783a1e69d8ecb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Fibrinolysis
108 rdf:type schema:DefinedTerm
109 Na90b9e38dc3448228840ded60ac722ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Ticlopidine
111 rdf:type schema:DefinedTerm
112 Nb7393eb4a1754d568759cf8698813f05 schema:volumeNumber 31
113 rdf:type schema:PublicationVolume
114 Nb85b676f3a2d45118e890c87c349b73f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Thrombolytic Therapy
116 rdf:type schema:DefinedTerm
117 Nbb5bc713db1a4a849e19fb8310e2e5de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Platelet Aggregation Inhibitors
119 rdf:type schema:DefinedTerm
120 Nbc62b644141347a1975f0b23a24f2844 rdf:first sg:person.01170266326.83
121 rdf:rest Na125bffad4234c5ebc0cb37375e3637a
122 Ncf47bc261f4d49d184e084e00c843acc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Adult
124 rdf:type schema:DefinedTerm
125 Nd5476475b7bb4d3bb0bbee93e7ca43db schema:name dimensions_id
126 schema:value pub.1050694479
127 rdf:type schema:PropertyValue
128 Nd8e75a247ddf4ac8942a38aada8f5ab3 rdf:first sg:person.0714034144.03
129 rdf:rest N5ee822f26efc4408b1701e097afb5f8e
130 Necaaa571ef7e481793828ce6cd931dc6 rdf:first sg:person.01172544713.06
131 rdf:rest Nd8e75a247ddf4ac8942a38aada8f5ab3
132 Ned4bbed6b3ed4dfe9dc191ea261a3cf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Humans
134 rdf:type schema:DefinedTerm
135 Nee2b0ed244e64a22804875d73ce77aa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Aged
137 rdf:type schema:DefinedTerm
138 Nff5f80ec486c4e4092b8cfeac46093e0 schema:name nlm_unique_id
139 schema:value 9502018
140 rdf:type schema:PropertyValue
141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
142 schema:name Medical and Health Sciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
145 schema:name Cardiorespiratory Medicine and Haematology
146 rdf:type schema:DefinedTerm
147 sg:journal.1113719 schema:issn 0929-5305
148 1573-742X
149 schema:name Journal of Thrombosis and Thrombolysis
150 rdf:type schema:Periodical
151 sg:person.01170266326.83 schema:affiliation https://www.grid.ac/institutes/grid.492942.0
152 schema:familyName Ahmed
153 schema:givenName Shaheeda
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170266326.83
155 rdf:type schema:Person
156 sg:person.01172544713.06 schema:affiliation https://www.grid.ac/institutes/grid.492942.0
157 schema:familyName Cannon
158 schema:givenName Christopher P.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172544713.06
160 rdf:type schema:Person
161 sg:person.01367356600.00 schema:affiliation https://www.grid.ac/institutes/grid.492942.0
162 schema:familyName Sabatine
163 schema:givenName Marc S.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367356600.00
165 rdf:type schema:Person
166 sg:person.0714034144.03 schema:affiliation https://www.grid.ac/institutes/grid.492942.0
167 schema:familyName Murphy
168 schema:givenName Sabina A.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714034144.03
170 rdf:type schema:Person
171 sg:person.0750215673.07 schema:affiliation https://www.grid.ac/institutes/grid.492942.0
172 schema:familyName Michael Gibson
173 schema:givenName C.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750215673.07
175 rdf:type schema:Person
176 sg:pub.10.1007/s11239-008-0197-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1047716313
177 https://doi.org/10.1007/s11239-008-0197-y
178 rdf:type schema:CreativeWork
179 https://app.dimensions.ai/details/publication/pub.1075017372 schema:CreativeWork
180 https://app.dimensions.ai/details/publication/pub.1082398326 schema:CreativeWork
181 https://doi.org/10.1016/j.ahj.2004.11.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002554441
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.ahj.2008.07.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009216476
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.ehj.2004.08.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054732660
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.jacc.2003.06.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015730556
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/j.jacc.2007.05.049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000216862
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/j.jacc.2009.10.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046464720
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0735-1097(02)02956-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041326817
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1055/s-2004-835678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057439294
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1056/nejmoa041365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017147712
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1056/nejmoa050522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028133368
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1093/eurheartj/ehl149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025653553
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1093/eurheartj/ehp492 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039022027
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1097/01.hjr.0000220582.19516.a6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060330237
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1159/000189522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008486067
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1161/01.cir.0000027560.41358.b3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002360004
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1161/01.cir.0000095676.90936.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038647312
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1161/01.cir.101.2.125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043155754
214 rdf:type schema:CreativeWork
215 https://doi.org/10.7326/0003-4819-139-2-200307150-00013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073706427
216 rdf:type schema:CreativeWork
217 https://www.grid.ac/institutes/grid.492942.0 schema:alternateName Thrombolysis in Myocardial Infarction Study Group
218 schema:name TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham Women’s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, 02115, Boston, MA, USA
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...